Healthcare Innovation

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

A $350,000 donation from prominent philanthropists will equip TGH's new Taneja Tower with a state-of-the-art iMRI, transforming brain surgery.

The bakery giant announced its 94th straight quarterly dividend, but a weak 2026 forecast and high payout ratio raise questions about its sustainability.

New data on leronlimab reveals striking long-term survival signals in heavily pretreated mTNBC patients, hinting at a new way to fight the disease.

Mayo Clinic implements Dock Health's platform to automate workflows, reduce clinician burden, and ensure patient care plans don't fall through the cracks.

The virtual care provider extends its specialized behavioral health services for Medicare patients to Arizona, Illinois, and Indiana amid a provider shortage.

A landmark study finds nearly half of Americans use OTC drugs weekly, revealing a quiet revolution in self-care that challenges current healthcare policy.

New head-to-head study results for POSLUMA PET imaging could redefine diagnostic clarity for prostate cancer, promising earlier and more precise detection.

As Adagene presents at key conferences, its SAFEbody tech and lead drug muzastotug draw focus amid a strategic push for funding and partnerships.

Strategic operator Exa Capital acquires clinical workforce leader StaffReady, betting its 'forever' investment model can boost healthcare efficiency.

After a 1,000% stock surge on promising clinical data, Nektar Therapeutics secures $460M, fueling its next chapter in immunotherapy amid high hopes and risks.

Toymaker Battat enters the adult hobby market with Arkitec, a new line of premium 3D puzzles under $20, blending mindfulness with affordability.

As demand for versatile, coverage-focused activewear soars, a California brand is expanding globally by focusing on a powerful, underserved demographic.

DifGen Pharmaceuticals' new FDA-approved generic eye drop is only the second of its kind, promising to increase competition and lower costs for patients.

A nonprofit's Super Bowl ad with Mike Tyson declared war on processed food. Who's behind the campaign, and can it change how America eats?

The Oreo maker's latest dividend declaration reinforces its reliability for investors, even as it navigates cost pressures and shifting consumer habits.

With its expansion into 187 Costco stores, Levels protein is proving that consumer demand for transparent, minimal-ingredient supplements is now mainstream.

Dr. Ginna Laport, a leader from both pharma and academia, joins NMDP to spearhead a new initiative aimed at making life-saving cell therapies a reality for more patients.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.